Therapy-related myelodysplasia and acute myeloid leukemia
about
Therapy-related myeloid neoplasms - what have we learned so far?PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directionsPediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Blood disorders typically associated with renal transplantation5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature.Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytesRisk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer RegistriesA systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromesStudy of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Acute myeloid leukemia following solid organ transplantation: entity or novelty?Therapy-related myelodysplastic syndrome.Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.Safety evaluation of olaparib for treating ovarian cancer.Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma.A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation.Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience.Myelodysplastic syndromes in Chernobyl clean-up workers.Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma.Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer.Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature.Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS).Inhibition of Pol I Transcription a New Chance in the Fight Against Cancer.Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.
P2860
Q28071318-4A686C94-009A-49C6-B15D-4606139BB873Q28071345-0B430B8F-30B1-4A12-8DC0-7B2C9E0AC8B0Q30248284-673E4889-1301-4F9E-B0C9-B1105640C812Q33421793-F09FAFA1-4F29-42EE-8B7C-3EC51D2763F4Q33437345-4362A7A5-FAAC-4893-A8C4-BCE7EF19CA1DQ35606212-20B6BAA4-F632-4B3F-B21E-CA427B57805CQ35868168-E9B5EC1F-A70A-43D2-92CB-2A6062A47471Q35947024-F43CE2B2-7662-43A4-866A-E778D42F2B7AQ36282672-E2D7EDCA-C2BE-4805-98AD-CD7F7C10AA0FQ36611288-9151FB46-BDDF-4CD9-8287-1894CEA73923Q36846660-EDE62DC9-3124-4A8C-B5FC-9D6CA73E7192Q37592412-94221646-84D0-4FC0-B285-9E080B6FDBC1Q37624593-C83D413B-BB43-457A-A805-05693B79A8C7Q38188011-40F4B36A-E751-4461-B528-6E5B4839C9C6Q38353167-A715EE29-8729-4EB3-84B5-14D564883636Q38407872-6FC98407-4D2D-4398-8AC9-DAD2367BBDD0Q38519719-58BDB28F-79CD-4C97-B406-8D30B2FB6B18Q39129413-6B186D79-69C2-4729-9CEA-A34928AAD859Q39135249-A2FAA0D8-2E22-422D-A069-CF777E1AFFE5Q40095482-7EEA74A4-523B-40BB-AA9A-BFEA754F8032Q40122866-E82B3950-D0E1-40F2-8396-A79BE8C27354Q40345824-111B401D-DA30-43BF-BD5E-3892894F0578Q40699238-374C65A6-231F-434D-B54D-928A01A2CD12Q40974681-27F11006-6F26-45B0-A7D0-F3253D454D7AQ41444373-37CB8762-1B9B-409F-B131-01427E88FAFAQ42363382-C01758AB-7371-4456-8855-D51708A5BD80Q49233865-452A4CE3-005F-4C7A-ACFF-CD95E3BD8687Q49338306-7A81EC63-AA2C-4051-A691-7460C76C110CQ49656307-65BF4085-B455-46BA-A0D6-CB238BEC6C95Q51806197-60E409B2-8D9C-43B6-B659-17EA64913704
P2860
Therapy-related myelodysplasia and acute myeloid leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapy-related myelodysplasia and acute myeloid leukemia
@en
Therapy-related myelodysplasia and acute myeloid leukemia.
@nl
type
label
Therapy-related myelodysplasia and acute myeloid leukemia
@en
Therapy-related myelodysplasia and acute myeloid leukemia.
@nl
prefLabel
Therapy-related myelodysplasia and acute myeloid leukemia
@en
Therapy-related myelodysplasia and acute myeloid leukemia.
@nl
P2860
P1433
P1476
Therapy-related myelodysplasia and acute myeloid leukemia
@en
P2093
Smita Bhatia
P2860
P304
P356
10.1053/J.SEMINONCOL.2013.09.013
P577
2013-12-01T00:00:00Z